Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

letter

. 2021 Oct 21;89(3):313–314. [Article in French] doi: 10.1016/j.rhum.2021.10.560

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2021 Published by Elsevier Masson SAS on behalf of Société Française de Rhumatologie.

Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

PMC Copyright notice

Fig. 1 — Évolution de la proportion de patients ayant eu au moins 1 délivrance d’une biothérapie ou d’un inhibiteur de Janus kinase initié en 2020 et comparée à celle de 2019. Confinement : du 16 mars au 10 mai 2020 ; ABA : abatacept, JAKi : Janus kinase inhibiteur ; Initiation : Traitement non dispensé dans les 12 mois précédents.

Base de données LRx.